JP2016526920A5 - - Google Patents

Download PDF

Info

Publication number
JP2016526920A5
JP2016526920A5 JP2016533383A JP2016533383A JP2016526920A5 JP 2016526920 A5 JP2016526920 A5 JP 2016526920A5 JP 2016533383 A JP2016533383 A JP 2016533383A JP 2016533383 A JP2016533383 A JP 2016533383A JP 2016526920 A5 JP2016526920 A5 JP 2016526920A5
Authority
JP
Japan
Prior art keywords
replication competent
recombinant replication
competent retrovirus
retrovirus
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016533383A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016526920A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/049831 external-priority patent/WO2015021077A1/en
Publication of JP2016526920A publication Critical patent/JP2016526920A/ja
Publication of JP2016526920A5 publication Critical patent/JP2016526920A5/ja
Pending legal-status Critical Current

Links

JP2016533383A 2013-08-05 2014-08-05 最適化ａ−バルジを有する組換えベクター Pending JP2016526920A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361862433P 2013-08-05 2013-08-05
US61/862,433 2013-08-05
PCT/US2014/049831 WO2015021077A1 (en) 2013-08-05 2014-08-05 Recombinant vector with optimized a-bulge

Publications (2)

Publication Number Publication Date
JP2016526920A JP2016526920A (ja) 2016-09-08
JP2016526920A5 true JP2016526920A5 (cg-RX-API-DMAC7.html) 2017-09-14

Family

ID=52461883

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016533383A Pending JP2016526920A (ja) 2013-08-05 2014-08-05 最適化ａ−バルジを有する組換えベクター

Country Status (6)

Country Link
EP (1) EP3030659A4 (cg-RX-API-DMAC7.html)
JP (1) JP2016526920A (cg-RX-API-DMAC7.html)
CN (1) CN105579581A (cg-RX-API-DMAC7.html)
AU (1) AU2014306093A1 (cg-RX-API-DMAC7.html)
CA (1) CA2920049A1 (cg-RX-API-DMAC7.html)
WO (1) WO2015021077A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201710973D0 (en) 2017-07-07 2017-08-23 Avacta Life Sciences Ltd Scaffold proteins
EP3856910B1 (en) 2018-09-24 2024-11-20 Merck Sharp & Dohme LLC Expression vectors for eukaryotic expression systems
TWI883032B (zh) 2019-08-12 2025-05-11 中國大陸商北京恩瑞尼生物科技股份有限公司 藉由adcc靶向cd39表現細胞促進及增強t細胞介導免疫反應之方法及組合物
WO2021063366A1 (zh) * 2019-09-30 2021-04-08 中国科学院上海药物研究所 用于治疗动脉相关疾病的药物及其用途
WO2021074695A1 (en) 2019-10-16 2021-04-22 Avacta Life Sciences Limited PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES.
JP2023525720A (ja) * 2020-05-11 2023-06-19 アビタス バイオ インコーポレイティッド Ｉｎ ｖｉｖｏ形質導入のためのベクター及び方法
GB202101299D0 (en) 2020-06-09 2021-03-17 Avacta Life Sciences Ltd Diagnostic polypetides and methods
CN117043194A (zh) 2021-01-29 2023-11-10 默沙东有限责任公司 程序性死亡受体1（pd-1）抗体的组合物以及获得所述组合物的方法
WO2022234003A1 (en) 2021-05-07 2022-11-10 Avacta Life Sciences Limited Cd33 binding polypeptides with stefin a protein
US20250243277A1 (en) 2021-10-07 2025-07-31 Avacta Life Sciences Limited Pd-l1 binding affimers
EP4412711A1 (en) 2021-10-07 2024-08-14 Avacta Life Sciences Limited Serum half-life extended pd-l1 binding polypeptides
AU2023262112A1 (en) 2022-04-29 2024-10-31 Purinomia Biotech, Inc. Methods and compositions for treating eosinophil driven diseases and disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937190A (en) * 1987-10-15 1990-06-26 Wisconsin Alumni Research Foundation Translation enhancer
US20050260568A1 (en) * 2004-04-30 2005-11-24 Min Gao Hepatitis C virus assays
MX2011003039A (es) * 2008-09-26 2011-08-15 Tocagen Inc Vectores de terapia genica y citosina deaminasas.
US8829173B2 (en) * 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
US20110020814A1 (en) * 2009-06-05 2011-01-27 Ipierian, Inc. Methods and compositions for selection of stem cells
CN102459616A (zh) * 2009-06-17 2012-05-16 托卡根公司 复制型逆转录病毒载体的生产细胞

Similar Documents

Publication Publication Date Title
JP2016526920A5 (cg-RX-API-DMAC7.html)
EP2909324B1 (en) Retroviral vector with mini-promoter cassette
US11279949B2 (en) Recombinant vectors comprising 2A peptide
US11788101B2 (en) Genomic insulator elements and uses thereof
US10975374B2 (en) Combination vectors and methods for treating cancer
EP3122884B1 (en) A retroviral vector having immune-stimulating activity
JP2012503986A5 (cg-RX-API-DMAC7.html)
JP2015533510A5 (cg-RX-API-DMAC7.html)
JP2012503987A5 (cg-RX-API-DMAC7.html)
EP3876952A1 (en) Vector system for expressing regulatory rna
JP2019503653A5 (cg-RX-API-DMAC7.html)
EP3030659A1 (en) Recombinant vector with optimized a-bulge
JP2023503858A (ja) ４－１ｂｂｌアジュバント添加した組み換え改変ワクシニアウイルスアンカラ（ｍｖａ）の医学的使用
Everson et al. Retroviral vector interactions with hematopoietic cells
JP7378152B2 (ja) Ｓｓｅａ４に結合するキメラ抗原受容体及びその使用
Abaan et al. Gene therapy in human breast cancer
Weber et al. Retroviral vectors
US11970708B2 (en) Gene therapy vector with minimizing recombination, recombinant retrovirus comprising the vector, and pharmaceutical composition for preventing or treating cancer comprising the recombinant retrovirus
RU2697797C2 (ru) Генетическая конструкция для индукции пролиферации периферических моноцитов in vitro
EP4249596A1 (en) New gene recombinant vaccinia virus and utilization thereof
CN1162643A (zh) 用于癌症治疗的分子嵌合体的制备方法及应用
HK40034205A (en) Chimeric antigen receptors that bind to ssea4 and uses thereof
Rabson Fratricidal retroviruses: a new twist in gene therapy
WO2018073307A1 (en) Mlv-based gene therapy with mutated integrase coupled to peptides